Navigation Links
China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results
Date:8/11/2011

high-quality manufacturing facilities and promising pipeline, strong distribution network, and commercialization expertise."

Pipeline UpdateAs of June 30, 2011, China Pharma had nine pipeline drugs in different stages of active development. The development of three of such products is highlighted below:

  • The Company completed clinical trials of Candesartan, a front-line drug therapy for the treatment of hypertension. The Company has completed all testing procedures and currently awaits final SFDA production approval.
  • The Company completed clinical trials of Rosuvastatin, a generic form of Crestor, in December 2010 and has submitted an application for SFDA production approval.
  • The Company completed Phase I clinical trials of its novel cephalosporin-based combination antibiotic in September 2010. Phase I of the clinical trials focused on the study of clinical pharmacology as well as the evaluation of safety on the human body, while observing tolerance and pharmacokinetics to provide support for dosage and drug delivery design. The Company has entered Phase II clinical trials for this drug.

  • Conference CallThe Company will hold a conference call at 8:30 am ET on August 11, 2011 to discuss second quarter 2011 results. Listeners may access the call by dialing 1-866-831-6272 or 1-617-213-8859 for international callers, access code: 72860215. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com. A replay of the call will be accessible through August 18, 2011 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 99608603.

    Use of Non-GAAP Financial MeasuresGAAP results for the three months and six months ended June 30, 2011 and June 30, 2010 include the impact of gains from changes in value of derivative warrant liability. To supplement its consolidated financial statements presented on a GAAP basi
    '/>"/>

    SOURCE China Pharma Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
    2. China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
    3. China Sky One Medical Announces Second Quarter 2011 Results
    4. China Medical Technologies and Leica Microsystems Announce Collaboration
    5. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
    6. China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23
    7. China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011
    8. China Pharma Holdings, Inc. to Report Second Quarter 2011 Financial Results on August 11, 2011
    9. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
    10. China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011
    11. China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
    (Date:12/22/2014)... LUXEMBOURG , Dec. 22, 2014  ConvaTec, a ... Paul Moraviec has been appointed Interim Chief Executive Officer ... Mr. Moraviec succeeds Ken Berger .  "The Board ... service in leading ConvaTec over the past three years," ... Board of Directors.  "We are confident that the company ...
    (Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals Incorporated ... study of lonafarnib in patients with chronic hepatitis ... at the National Institutes of Health (NIH) Clinical ...  The double-blinded, randomized, placebo-controlled, dose ascending study evaluated ... and 200 mg twice daily for 28 days.  ...
    Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
    ... Adeona Pharmaceuticals, Inc. (NYSE Amex: ... serious central nervous system diseases, announced that the Company,s ... a new Phase II clinical trial to evaluate its ... multiple sclerosis (MS) patients. The Skirball Foundation and Adeona ...
    ... Connecticut, November 11, 2011 At RSNA ... Sectra   (NASDAQ OMX Stockholm: SECT B), ... tomosynthesis images in Sectra Breast Imaging PACS. ... PACS do not support images of this type, a dedicated ...
    Cached Medicine Technology:Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 2Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 3Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 4Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 5Sectra Launches Support for Breast Tomosynthesis Images in PACS 2
    (Date:12/22/2014)... As part of a company-wide ... in San Diego and surrounding areas, Golden ... care team with ongoing online training courses. , ... provided by Caregiverlist®. Caregiverlist® is “the premiere ... most reliable eldercare options, highest quality ratings and ...
    (Date:12/22/2014)... LENEXA, Kan. (PRWEB) December 22, 2014 ... it will add a subscription option to their ad ... for report writing services. Customers can sign up for ... report writing hours each month at a deeply discounted ... pricing tiers, and each has a progressively discounted rate. ...
    (Date:12/22/2014)... (PRWEB) December 22, 2014 ... current Ebola virus epidemic are receiving further ... government agencies, nongovernmental organizations (NGOs) and other ... ongoing, healthcare workers, emergency responders, patients and ... such as the CmTP MediDefense system ...
    (Date:12/22/2014)... NY (PRWEB) December 22, 2014 ... stronger than ever, having invested more than $5 ... service members, veterans and their families. , This ... nearly a dozen nonprofits, helping with: veteran entrepreneurship; ... scholarships; and life-coaches for severely injured veterans. , ...
    (Date:12/22/2014)... 2014 Give a loved one the ... of health and vitality. , For a limited time, ... anti-aging formulas in special Holiday Wellness gift packages at ... , Each bottle contains cutting-edge, proven nutritional support for ... as well as we age. , Joint ...
    Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
    ... , WEDNESDAY, Dec. 7 (HealthDay News) -- Hispanic women ... breast cancer than non-Hispanic white women, according to a ... could explain this discrepancy, the researchers suggested. "This ... is less responsive to chemotherapy," Kathy Baumgartner, an epidemiology ...
    ... mastectomy (CPM), a procedure that removes the unaffected breast ... a modest increase in life expectancy, according to a ... Medicine at the University of Pennsylvania. In fact, the ... quality-adjusted life expectancy a measure of life expectancy ...
    ... or adults, often takes place even in the absence ... Current methods to treat such overeating in youth focus ... them to track their food intake and engage in ... therapy techniques don,t work long term, according to Kerri ...
    ... HealthDay Reporter , WEDNESDAY, Dec. 7 (HealthDay News) ... with low-risk prostate cancer, a new draft report released ... concluded that research on the safety of "active surveillance" ... men opt for surgery or other treatments that can ...
    ... Autism Speaks Chief Science Officer Geri Dawson, Ph.D. and Assistant VP, ... Speaks "Office Hour: The Doctors Are In," a monthly live web ... each month from 3:00 - 4:00 pm Eastern / 12:00 noon ... At the time of the web chat, viewers simply log in ...
    ... to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is ... exposed to the virus. Having shown great promise in recent phase ... use. Because PrEP is based on the same ... is that the dual use of these drugs will lead to ...
    Cached Medicine News:Health News:Hispanic Women More Likely to Die of Breast Cancer 2Health News:Contralateral prophylactic mastectomy offers limited gains for breast cancer patients 2Health News:Contralateral prophylactic mastectomy offers limited gains for breast cancer patients 3Health News:New approach to management of overeating in children 2Health News:New approach to management of overeating in children 3Health News:Active Surveillance May Benefit Men With Low-Risk Prostate Cancer 2Health News:New Autism Speaks 'Office Hour: The Doctors Are In' monthly live web chat 2Health News:UCLA researchers suggest unconventional approach to control HIV epidemics 2Health News:UCLA researchers suggest unconventional approach to control HIV epidemics 3
    Full plate covers seal all 24 MicroAmp tubes...
    96-Well PCR Plate Sealing Mat...
    Easy to pierce, remove using foil stripper...
    Inquire...
    Medicine Products: